Literature DB >> 26583307

COMPARISON OF MANUAL AND SEMIAUTOMATED FUNDUS AUTOFLUORESCENCE ANALYSIS OF MACULAR ATROPHY IN STARGARDT DISEASE PHENOTYPE.

Laura Kuehlewein1, Amir H Hariri, Alexander Ho, Laurie Dustin, Yulia Wolfson, Rupert W Strauss, Hendrik P N Scholl, SriniVas R Sadda.   

Abstract

PURPOSE: To evaluate manual and semiautomated grading techniques for assessing decreased fundus autofluorescence (DAF) in patients with Stargardt disease phenotype.
METHODS: Certified reading center graders performed manual and semiautomated (region finder-based) grading of confocal scanning laser ophthalmoscopy (cSLO) fundus autofluorescence (FAF) images for 41 eyes of 22 patients. Lesion types were defined based on the black level and sharpness of the border: definite decreased autofluorescence (DDAF), well, and poorly demarcated questionably decreased autofluorescence (WDQDAF, PDQDAF). Agreement in grading between the two methods and inter- and intra-grader agreement was assessed by kappa coefficients (κ) and intraclass correlation coefficients (ICC).
RESULTS: The mean ± standard deviation (SD) area was 3.07 ± 3.02 mm for DDAF (n = 31), 1.53 ± 1.52 mm for WDQDAF (n = 9), and 6.94 ± 10.06 mm for PDQDAF (n = 17). The mean ± SD absolute difference in area between manual and semiautomated grading was 0.26 ± 0.28 mm for DDAF, 0.20 ± 0.26 mm for WDQDAF, and 4.05 ± 8.32 mm for PDQDAF. The ICC (95% confidence interval) for method comparison was 0.992 (0.984-0.996) for DDAF, 0.976 (0.922-0.993) for WDQDAF, and 0.648 (0.306-0.842) for PDQDAF. Inter- and intra-grader agreement in manual and semiautomated quantitative grading was better for DDAF (0.981-0.996) and WDQDAF (0.995-0.999) than for PDQDAF (0.715-0.993).
CONCLUSION: Manual and semiautomated grading methods showed similar levels of reproducibility for assessing areas of decreased autofluorescence in patients with Stargardt disease phenotype. Excellent agreement and reproducibility were observed for well demarcated lesions.

Entities:  

Mesh:

Year:  2016        PMID: 26583307     DOI: 10.1097/IAE.0000000000000870

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  18 in total

1.  Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).

Authors:  Rupert W Strauss; Beatriz Muñoz; Alexander Ho; Anamika Jha; Michel Michaelides; Artur V Cideciyan; Isabelle Audo; David G Birch; Amir H Hariri; Muneeswar G Nittala; SriniVas Sadda; Sheila West; Hendrik P N Scholl
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

2.  CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Irene Leung; Ferenc B Sallo; Roberto Bonelli; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

3.  Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.

Authors:  Rupert W Strauss; Beatriz Muñoz; Alex Ho; Anamika Jha; Michel Michaelides; Saddek Mohand-Said; Artur V Cideciyan; David Birch; Amir H Hariri; Muneeswar G Nittala; SriniVas Sadda; Hendrik P N Scholl
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

4.  Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease.

Authors:  Stanley Lambertus; Nathalie M Bax; Ana Fakin; Joannes M M Groenewoud; B Jeroen Klevering; Anthony T Moore; Michel Michaelides; Andrew R Webster; Gert Jan van der Wilt; Carel B Hoyng
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

5.  Comparison of Green Versus Blue Fundus Autofluorescence in ABCA4-Related Retinopathy.

Authors:  Philipp L Müller; Maximilian Pfau; Matthias M Mauschitz; Philipp T Möller; Johannes Birtel; Petrus Chang; Martin Gliem; Steffen Schmitz-Valckenberg; Monika Fleckenstein; Frank G Holz; Philipp Herrmann
Journal:  Transl Vis Sci Technol       Date:  2018-10-01       Impact factor: 3.283

6.  Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8.

Authors:  Kaoru Fujinami; Rupert W Strauss; John Pei-Wen Chiang; Isabelle S Audo; Paul S Bernstein; David G Birch; Samantha M Bomotti; Artur V Cideciyan; Ann-Margret Ervin; Meghan J Marino; José-Alain Sahel; Saddek Mohand-Said; Janet S Sunness; Elias I Traboulsi; Sheila West; Robert Wojciechowski; Eberhart Zrenner; Michel Michaelides; Hendrik P N Scholl
Journal:  Br J Ophthalmol       Date:  2018-06-20       Impact factor: 4.638

7.  Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy.

Authors:  Enrico Borrelli; Muneeswar Gupta Nittala; Nizar Saleh Abdelfattah; Jianqin Lei; Amir H Hariri; Yue Shi; Wenying Fan; Mariano Cozzi; Valentina Sarao; Paolo Lanzetta; Giovanni Staurenghi; SriniVas R Sadda
Journal:  Br J Ophthalmol       Date:  2018-06-05       Impact factor: 4.638

8.  Prospective Cohort Study of Childhood-Onset Stargardt Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-Onset Disease, and Disease Symmetry.

Authors:  Michalis Georgiou; Thomas Kane; Preena Tanna; Zaina Bouzia; Navjit Singh; Angelos Kalitzeos; Rupert W Strauss; Kaoru Fujinami; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2019-12-06       Impact factor: 5.258

9.  Systemic complement activation levels in Stargardt disease.

Authors:  Patty P A Dhooge; Esmee H Runhart; Catherina H Z Li; Corrie M de Kat Angelino; Carel B Hoyng; Renate G van der Molen; Anneke I den Hollander
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

10.  Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular Dystrophy.

Authors:  Rupert W Strauss; Beatriz Muñoz; Anamika Jha; Alexander Ho; Artur V Cideciyan; Melissa L Kasilian; Yulia Wolfson; SriniVas Sadda; Sheila West; Hendrik P N Scholl; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2016-06-11       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.